Valeant hinted at the prospect of a higher takeover offer for Botox maker Allergan, which raised its guidance for the year on Monday, as both companies angle for support ahead of key deadlines.
from WSJ.com: US Business http://ift.tt/1pQ7AI7
via IFTTT
from WSJ.com: US Business http://ift.tt/1pQ7AI7
via IFTTT
No comments:
Post a Comment